PART TWO
Diagnostic Cytology
32.
Wright C, Pipingas A, Grayson W, et al.
Pemphigus vulgaris of the uterine cervix
revisited: case report and review of the
literature.
Diagn Cytopathol
2000;22:
304-307.
33.
Kapila K, Verma K. Intracellular bacilli
in vaginal smears in a case of malaco-
plakia of the uterine cervix.
Acta Cytol
1989;33:410-411.
33a. Angrish K, Verma K. Cytologic detection
of tuberculosis of the uterine cervix.
Acta Cytol
1981;25(2):160-2.
34.
Qualman SJ, Gupta Pk, Mendelsohn G.
Intracellular
Escherichia coli
in urinary
malakoplakia: a reservoir of infection
and its therapeutic implications.
Am J
Clin Pathol
1984;81:35-42.
35.
Case record of the Massachuttes
General Hospital.
N Eng J Med
1970;282:862-868.
36.
Thomas R, Barnhill D, Bibro M, et al.
Histiocytosis-X in gynecology: a case
presentation and review of the litera-
ture.
Obstet Gynecol
1986;67:46S-49S.
37.
Kumari TR, Kini U. Unraveling the mys-
tique case of pseudotumor syndrome of
pelvis.
Diagn Cytopathol
2007;35:67-70.
38.
Gupta PK. Intrauterine contraceptive
devices: vaginal cytology, pathologic
changes and clinical implications.
Acta
Cytol
1982;26:571-613.
39.
Burkman R, Schlesselman S, McCaffrey L,
et al. The relationship of genital tract
actinomycetes and the development of
pelvic inflammatory disease.
Am J Obstet
Gynecol
1982;143:585-589.
40.
Luff RD, Gupta PK. Actinomycetes-like
organisms in wearers of intrauterine
contraceptive devices.
Am J Obstet Gyne-
col
1977;129:476-477.
41.
de la Monte SM, Gupta PK, White CL
3rd. Systemic
Actinomyces
infection.
A potential complication of intrau-
terine contraceptive devices.
JAMA
1982;248:1876-1877.
42.
Hager WD, Majmudar B. Pelvic actino-
mycosis in women using intrauterine
contraceptive devices.
Am J Obstet
Gynecol
1979;133:60-63.
43.
Gupta PK, Hollander DH, Frost JK.
Actinomycetes in cervico-vaginal
smears: an association with IUD usage.
Acta Cytol
1976;20:295-297.
44.
Shurbaji MS, Gupta PK, Myers J.
Immunohistochemical demonstration
of Chlamydial antigens in association
with prostatitis.
Mod Pathol
1988;1:348-
351.
45.
de Moraes-Ruehsen M, McNeill R, Frots
J. Amebae resembling
Entamoeba gingi-
valis
in the genital tracts of IUD users.
Acta Cytol
1980;24:413-420.
46.
Bibbo M, Harris M, Wied G (eds).
Micro-
biology and Inflammation of the Female
Genital Tract
. Chicago: Tutorials of
Cytology; 1976.
47.
Gupta PK, Burroughs F, Luff RD, et al.
Epithelial atypias associated with intra-
uterine contraceptive devices (IUD).
Acta Cytol
1978;22:286-291.
48.
Graham R (ed.).
The Cytologic Diagnosis
of Cancer,
3rd edn. Philadelphia:
Wb Saunders; 1972.
48a. Lipshutz B. Untersuchungen über die
aetiologic der krankeiten der herpes-
gruppe.
Arch Derm Syph (Berlin)
1921;136-428.
49.
Mardh PA, Stormby N, Westrom L.
Mycoplasma and vaginal cytology.
Acta
Cytol
1971;15:310-315.
50.
Roberts TH, Ng AB. Chronic lym-
phocytic cervicitis: cytologic and his-
topathologic manifestations.
Acta Cytol
1975;19:235-243.
51.
Halford JA. Cytological features of
chronic follicular cervicitis in liquid-
based specimens: a potential diagnostic
pitfall.
Cytopathology
2002;13:364-370.
52.
Gupta PK, Lee EF, Erozan YS, et al.
Cytologic investigations in
Chlamydia
infection.
Acta Cytol
1979;23:315-320.
53.
Taylor-Robinson D, Thomas BJ. The role
of
Chlamydia trachomatis
in genital-tract
and associated diseases.
J Clin Pathol
1980;33:205-233.
54.
Hollander DH, Gupta PK. DCT,
CCP and pseudoprotozoa.
Acta Cytol
1979;23:258-259.
55.
Schneweis KE. [On the antigenic struc-
ture of herpes simplex virus.].
Z Immun
exp ther.
1962;124:173-196.
56.
McDougall J (ed.).
In Situ Cytological
Hybridization to Detect Herpes Simplex
Virus RNA in Human Tissue
. New York:
Plenum; 1979.
57.
Anthony DD, Wentz WB, Reagan JW,
et al. Induction of cervical neoplasia
in the mouse by herpes simplex virus
type 2 DNA.
Proc Natl Acad Sci USA
1989;86:4520-4524.
58.
Aurelian L, Gupta PK, Frost JK, et al.
Fluorescence-activated separation
of cervical abnormal cells using herpes-
virus antigenic markers.
Anal Quant
Cytol
1979;1:89-102.
59.
Gilman SC, Docherty JJ, Clarke A, et
al. Reaction patterns of herpes simplex
virus type 1 and type 2 proteins with
sera of patients with uterine cervical car-
cinoma and matched controls.
Cancer
Res
1980;40:4640-4647.
60.
Gupta PK, Aurelian L, Frost JK, et
al. Herpesvirus antigens as mark-
ers for cervical cancer.
Gynecol Oncol
1981;12:S232-258.
61.
Jones KW, Fenoglio CM, Shevchuk-
Chaban M, et al. Detection of herpes sim-
plex virus type 2 mRNA in human cervical
biopsies by in situ cytological hybridiza-
tion.
ARC Sci Publ
1978:917-925.
62.
Kessler II. Venereal factors in human
cervical cancer: evidence from marital
clusters.
Cancer
1977;39:1912-1919.
63.
Vesterinen E, Purola E, Saksela E, et
al. Clinical and virological findings in
patients with cytologically diagnosed
gynecologic herpes simplex infections.
Acta Cytol
1977;21:199-205.
64.
Corey L (ed.).
Genital Herpes.
New York:
McGraw Hill; 1984.
65.
Lipschutz B (ed.).
Untersuchunger uber
die aetiologic der krankheiten der
herpesgruppe
. Berlin: Arch Derm Syph;
1921;136.
66.
US Department of Health and Human
Services, Public Health Service.
Sexually
Transmitted Disease Fact Sheet,
39th edn:
Centers for Disease Control, Atlanta; 1981.
67.
Patten SJ (ed.).
Diagnostic Cytopathology
of the Uterine Cervix,
2nd edn. 1978.
68.
Kumar ML, Gold E, Jacobs IB, et al.
Primary cytomegalovirus infection
in adolescent pregnancy.
Pediatrics
1984;74:493-500.
69.
Griffiths PD, Campbell-Benzie A,
Heath RB. A prospective study of
primary cytomegalovirus infection in
pregnant women.
Br J Obstet Gynaecol
1980;87:308-314.
70.
Naib Z (ed.).
Exfoliative Cytopathology,
3rd edn. Boston: Little Brown; 1985.
71.
Koutsky L. Epidemiology of genital
human papillomavirus infection.
Am J
Med
1997;102:3-8.
72.
Meisels A, Fortin R. Condylomatous
lesions of the cervix and vagina. I. Cyto-
logic patterns.
Acta Cytol
1976;20:505-509.
72a. Munoz N, Bosch FX, de Sanjosé S,
et al. Epidemiologic classification of
human papillomavirus types associ-
ated with cervical cancer.
N Engl J Med
2003;348(6):518-27.
72b. Cogliano V, Baan R, Straif K, et al.
WHO International Agency for Research on
Cancer. Carcinogenicity of human papil-
lomaviruses.
Lancet Oncol
2005;6(4):204.
73.
Koss L, Melamed M (eds.).
Koss' Diag-
nostic Cytology and Its Histopathologic
Bases
, 5th edn. Philadelphia: Lippincott
Williams and Wilkins; 2006.
74.
Broker T, Butcher M (eds).
Papilloma-
viruses: Retrospectives and prospectives
.
Cold Spring Harbor, NY: Cold Spring
Harbor Publications; 1986.
75.
Bosch FX, Manos MM, Munoz N, et al.
Prevalence of human papillomavirus in
cervical cancer: a worldwide perspective.
International biological study on cervical
cancer (IBSCC) Study Group.
J Natl
Cancer Inst
1995;87:796-802.
76.
Walboomers JM, Jacobs MV, Manos
MM, et al. Human papillomavirus is a
necessary cause of invasive cervical can-
cer worldwide.
J Pathol
1999;189:12-19.
77.
Sherman ME, Lorincz AT, Scott DR, et al.
Baseline cytology, human papillomavi-
rus testing, and risk for cervical neopla-
sia: a 10-year cohort analysis.
J Natl Cancer Inst
2003;95:46-52.
78.
zur Hausen H. Papillomaviruses in human
cancer.
Cancer
1987;59:1692-1696.
79.
Crum CP, Berkowitz RS. Human papil-
lomaviruses. Applications, caveats and
prevention.
J Reprod Med
2002;47:519-
528; discussion 528-529.
80.
Duensing S, Lee LY, Duensing A, et al.
The human papillomavirus type 16 E6
and E7 oncoproteins cooperate to induce
mitotic defects and genomic instability
by uncoupling centrosome duplication
from the cell division cycle.
Proc Natl
Acad Sci USA
2000;97:10,002-10,007.
81.
Heselmeyer K, Schrock E, du Manoir S,
et al. Gain of chromosome 3q defines
the transition from severe dysplasia to
invasive carcinoma of the uterine cervix.
Proc Natl Acad Sci USA
1996;93:479-484.
82.
Klingelhutz AJ, Foster SA, McDougall
JK. Telomerase activation by the E6 gene
product of human papillomavirus type
16.
Nature
1996;380:79-82.
83.
Munger K, Howley PM. Human
papillomavirus immortalization and
transformation functions.
Virus Res
2002;89:213-228.
84.
Khan M, Castle P, Lorincz A. The elevated
10-year risk of cervical precancer and can-
cer in women with human papillomavi-
rus (HPV) type 16 or 18 and the possible
utility of type-specific HPV testing
128
previous page 130 ComprehensiveCytopathology 1104p 2008 read online next page 132 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off